Lascunia, Grevi O.

HRN: 15-51-48  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2025
CEFTRIAXONE 1G (VIAL)
08/08/2025
08/15/2025
IV
2g
OD
Burn
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: